CYTKCytokinetics, Incorporated

CYTK Stock Price, Valuation & Chart | Cytokinetics, Incorporated

Compare

$71.400+0.49 (+0.69%)

At close · 01 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology CYTK intrinsic value CYTK calculated fair value vs price

Overview Financials Dividends Ratios

CYTK Historical price chart

CYTK Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization8.88B

PE Ratio-9.89

EPS-7.22

Trading Volume1.90M

Today's High/Low72.44/69.85

Dividend Yield0.00

52 Week High/Low88.31/44.91

Shares Outstanding124.43M

CYTK Financial Statement

CYTK Analyst ratings

CYTK Analysis & performance metrics

CYTK Company profile

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential…

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac…

CYTK Management team

Name

Position

Robert I. BlumCEO

Chief Executive Officer, President & Director

Sung H. LeeCFO

EVice President & Chief Financial Officer

Matt Yang

Vice President of Corporate Finance and Financial Planning & Analysis

Holly Laughlin

Vice President of Accounting & Corporate Controller

Kari K. Loeser J.D.

Vice President & Chief Compliance Officer

Andrew M. Callos

Executive Vice President & Chief Commercial Officer

Steven M. Cook J.D.

Senior Vice President of Global Supply Chain Operations & Technical Operations

Jeff Lotz

Vice President of Sales & Operations

Name

Position

Robert I. BlumCEO

Chief Executive Officer, President & Director

Sung H. LeeCFO

EVice President & Chief Financial Officer

Matt Yang

Vice President of Corporate Finance and Financial Planning & Analysis

Holly Laughlin

Vice President of Accounting & Corporate Controller

Kari K. Loeser J.D.

Vice President & Chief Compliance Officer

Andrew M. Callos

Executive Vice President & Chief Commercial Officer

Steven M. Cook J.D.

Senior Vice President of Global Supply Chain Operations & Technical Operations

Jeff Lotz

Vice President of Sales & Operations

Management Team

Robert I. BlumCEO

Chief Executive Officer, President & Director

Sung H. LeeCFO

EVice President & Chief Financial Officer

Matt Yang

Vice President of Corporate Finance and Financial Planning & Analysis

Holly Laughlin

Vice President of Accounting & Corporate Controller

Kari K. Loeser J.D.

Vice President & Chief Compliance Officer

Andrew M. Callos

Executive Vice President & Chief Commercial Officer

Steven M. Cook J.D.

Senior Vice President of Global Supply Chain Operations & Technical Operations

Jeff Lotz

Vice President of Sales & Operations

Management

Robert I. BlumCEO

Chief Executive Officer, President & Director

Sung H. LeeCFO

EVice President & Chief Financial Officer

Matt Yang

Vice President of Corporate Finance and Financial Planning & Analysis

Holly Laughlin

Vice President of Accounting & Corporate Controller

Kari K. Loeser J.D.

Vice President & Chief Compliance Officer

Andrew M. Callos

Executive Vice President & Chief Commercial Officer

Steven M. Cook J.D.

Senior Vice President of Global Supply Chain Operations & Technical Operations

Jeff Lotz

Vice President of Sales & Operations

Total 8 executives

CYTK Frequently asked questions

What is Cytokinetics, Incorporated (CYTK) Stock Price?

Current stock price of Cytokinetics, Incorporated (CYTK) stock is $71.400. The stock price is +0.69% higher in the session. The intraday range can be seen from this page. Volume of Cytokinetics, Incorporated (CYTK) stock is 1.90M.

Last updated at 01 Sept 2026, 08:00 pm.

Why is the Cytokinetics, Incorporated (CYTK) stock price going up or down today?

The stock price of Cytokinetics, Incorporated (CYTK) can change with earnings, company news, and overall market sentiment. Cytokinetics, Incorporated operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Cytokinetics, Incorporated stock expensive at its current price?

Whether Cytokinetics, Incorporated looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CYTK on this page is -9.89. EPS on this page is -7.22. Compare those figures with peers and growth expectations before deciding if the current Cytokinetics, Incorporated price is justified.

How has the stock price of Cytokinetics, Incorporated (CYTK) performed historically?

Historical performance for Cytokinetics, Incorporated (CYTK) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CYTK reacted to past earnings and market events.

Should I buy Cytokinetics, Incorporated (CYTK) stock, at this price?

Buying Cytokinetics, Incorporated (CYTK) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.